Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Healthtrust
Moodys
Fuji
Merck
McKesson
US Army
Cerilliant
Fish and Richardson

Generated: May 23, 2018

DrugPatentWatch Database Preview

LUMASON Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Lumason, and when can generic versions of Lumason launch?

Lumason is a drug marketed by Bracco and is included in one NDA. There is one patent protecting this drug.

This drug has one hundred and forty-one patent family members in twenty-eight countries.

The generic ingredient in LUMASON is sulfur hexafluoride lipid-type a microspheres. There are two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the sulfur hexafluoride lipid-type a microspheres profile page.
Summary for LUMASON
Drug patent expirations by year for LUMASON
Synonyms for LUMASON
[SF6]
2551-62-4
29267-82-1
36575-03-8
59109-69-2
A817889
AC1L29UB
ACMC-1CQA3
AKOS015960568
BRI
CHEBI:30496
CHEMBL1796998
CTK1A2580
D05962
DB11104
DTXSID8029656
EINECS 219-854-2
Elagas
Elegas
Esaflon
hexafluoridosulfur
hexafluoro-|E6-sulfane
hexafluoro-$l^{6}-sulfane
hexafluoro-l6-sulfane
Hexafluorosulfur
Hexafluorure de soufre
Hexafluorure de soufre [French]
hexakis(fluoranyl)-$l^{6}-sulfane
HSDB 825
IN002072
IN014321
LS-148165
MFCD00011447
MolPort-001-776-565
OC-6-11
PC6600
R 7146
SBB086453
SF6
SF6 Microbubbles
SFZCNBIFKDRMGX-UHFFFAOYSA-N
SonoVue
SonoVue (for the microbubble formulation)
Sonovue (TN)
Stabilized sulfur hexafluoride microbubbles
Sulfur fluoride (SF6)
Sulfur fluoride (SF6), (OC-6-11)-
Sulfur fluoride, (OC-6-11)-
SULFUR HEXAFLUORIDE
Sulfur hexafluoride (USAN)
Sulfur hexafluoride [UN1080] [Nonflammable gas]
Sulfur hexafluoride [UN1080] [Nonflammable gas]
Sulfur hexafluoride [USAN]
Sulfur hexafluoride lipid microsphere
Sulfur hexafluoride lipid-type A microspheres
Sulfur hexafluoride, >=99.75%
sulfur(6+) fluoride
sulfur(VI) fluoride
Sulfurhexafluoride
Sulfuric fluoride
Sulphur hexafluoride
TC-165101
UN 1080
UN1080
UNII-WS7LR3I1D6
WS7LR3I1D6
ZINC245224194

US Patents and Regulatory Information for LUMASON

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial Y Y ➤ Try a Free Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Bracco LUMASON sulfur hexafluoride lipid-type a microspheres FOR SUSPENSION;INTRAVENOUS 203684-001 Oct 15, 2014 RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Non-Orange Book US Patents for LUMASON

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,033,574 Stable microbubbles suspensions injectable into living organisms ➤ Try a Free Trial
6,183,725 Gas mixtures useful as ultrasound contrast media, contrast agents containing the media and method ➤ Try a Free Trial
5,567,414 Stable microbubbles suspensions injectable into living organisms ➤ Try a Free Trial
5,413,774 Long-lasting aqueous dispersions or suspensions of pressure-resistant gas-filled microvesicles and methods for the preparation thereof ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Supplementary Protection Certificates for LUMASON

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
/2001 Austria ➤ Try a Free Trial PRODUCT NAME: SCHWEFELHEXAFLUORID ENTHALTENDE, DURCH PHOSPHORLIPID STABILISIERTE MIKROBLAESCHEN; REGISTRATION NO/DATE: EU/1/01/177/001, EU/1/01/177/002 20010326
15/074 Ireland ➤ Try a Free Trial PRODUCT NAME: CEFTOLOZANE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, IN PARTICULAR A SULFURIC ACID SALT; REGISTRATION NO/DATE: EU/1/15/1032/001 20150918
00061 Netherlands ➤ Try a Free Trial PRODUCT NAME: ZWAVELHEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001-002 20010326
C0036 France ➤ Try a Free Trial PRODUCT NAME: SULPHUR HEXAFLUORIDE; REGISTRATION NO/DATE: EU/1/01/177/001 20010326
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Baxter
Colorcon
Julphar
Boehringer Ingelheim
Fuji
Mallinckrodt
Farmers Insurance
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.